<DOC>
	<DOCNO>NCT00597415</DOCNO>
	<brief_summary>The purpose study compare efficacy celecoxib versus placebo delay onset pain improve walk function subject knee Osteoarthritis</brief_summary>
	<brief_title>Efficacy Celecoxib 200mg Relieving Pain Walking Dysfunction Osteoarthritis Knee</brief_title>
	<detailed_description>We develop walk model safely reproducibly induces pain subject knee OA manner permit comparison effect different therapy pain control . In previous study , demonstrate self-paced 20 minute walk follow one-hour rest second coordinator-paced 20-minute walk well tolerate generate moderate severe pain participant within time frame walk . We use model , crossover design test efficacy celecoxib compare placebo control knee pain improvement walk function .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>If female childbearing potential , must use adequate contraception since last menses use adequate contraception study , Diagnosed OA knee Functional Capacity Classification III ( FCC ) If active analgesic antiinflammatory pain medication , must VAS pain score &gt; =30mm signal knee relate walk flat surface within previous 48 hour . Subjects take pain medication must VAS pain score &gt; =40mm signal knee At baseline visit , must history pain signal knee &gt; =40mm walk flat within previous 48 hour . In Investigator 's opinion , patient require eligible therapy antiinflammatory analgesic . If NSAID analgesic , patient must complete washout period prior baseline assessment minium five half life . The patient provide write informed consent undergo study procedure . Diagnosed inflammatory arthritis acute trauma index joint . Another painful condition would interfere his/her ability walk make reasonable assessment pain . Received injection corticosteroid signal knee within 3 month ; hyaluronan produce signal knee within previous 6 month . Requires use cane assistive device complete walk . Known cardiovascular disease symptomatic past 12 month History blood clot increase risk blood clot . Asthma breathe condition would preclude walk briskly 20 consecutive minute 40 minute total . Has take NSAIDs , COX2 inhibitor , analgesic , exception rescue acetaminophen , within two day prior Visit 2 Active malignancy type malignancy recur within 5 year enrollment . Diagnosed treated esophageal , gastric , pyloric channel , duodenal ulceration within 90 day Active GI disease , chronic acute renal hepatic disorder , significant coagulation defect . Any chronic illness laboratory abnormality consider clinically significant . Received investigational medication within 30 day Known hypersensitivity celecoxib , NSAIDs , sulfonamides Use follow drug : 1 . NSAIDs COX2 specific inhibitor 2 . Analgesics except rescue medication within 24 hour study visit 3 . Anticoagulants 4 . Lithium 5 . Glucosamine chondroitin sulfate exclude unless stable dose least 3 month</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>Knee pain</keyword>
</DOC>